Drug Research Topics
The On-Topic Netowork

Drug Research > Antibiotic Resistance

The following information is about Antibiotic Resistance.

Antibiotic Resistance Defined

The ability of a bacterium to resist or overcome the effects of an antibiotic.

This definition is in context to Drug Research. See more contextual defintions for Antibiotic Resistance.


Navigation: [ 1 2 Next ]

Newborn ICUs Seeing More Antibiotic-Resistant Staph Infections

Published July 2, 2009, 5:23 am, Medical News Today

The rate of methicillin-resistant Staphylococcus aureus (MRSA) infections in U.S. neonatal intensive care units (NICUs) has more than tripled in recent years, reports a study in the July issue of The Pediatric Infectious Disease Journal.

Full Story


Coral Fights Antibiotic Resistance

Published July 1, 2009, 6:06 am, Scientific American

Several years ago biochemists studying marine ecosystems noticed something unusual: a sponge thriving in the middle of a coral reef that was dying from a bacterial infection. The researchers identified a substance made by the sponge that defended it from harmful microbes and realized it was a natural antibacterial molecule called ageliferin. Ageliferin can break down the formation of a ...

Full Story


Calixa Therapeutics Announces Initiation Of Phase 2 Clinical Trial Of Its Antibiotic, CXA-101, In Patients With ...

Published July 1, 2009, 5:22 am, Medical News Today

Calixa Therapeutics Inc. today announced the initiation of a Phase 2 clinical trial of CXA-101 in patients with complicated urinary tract infections. CXA-101 is a new broad-spectrum, parenteral cephalosporin antibiotic with excellent in vitro and in vivo activity against Pseudomonas aeruginosa, including drug resistant isolates.

Full Story


Team Develops Anti-Infection Technology

Published June 30, 2009, 1:31 pm, Newswise

Combat-related injuries plague the military in part because of multidrug-resistant bacteria. Imagine being able to spray a compound fracture with microcapsules that deliver a drug to bolster the immune system, stopping infection before it starts. That technology might be around the corner, says Bingyun Li, Ph.D., of WVU.

Full Story


Rib-X Pharmaceuticals, Inc. Appoints Dr. Russell Greig to Board of Directors

Published June 30, 2009, 7:14 am, redOrbit

NEW HAVEN, Conn., June 30 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc., a development stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic resistant infections, announced today that Russell Greig, Ph.D., of SR One venture capital, has been appointed to the Company's Board of Directors.

Full Story


Research elite given dream run

Published June 30, 2009, 7:00 am, The Australian

CRACK research teams across the country are gearing up for a serious assault on challenges as diverse as superbugs, smart metals and sustainability, thanks to a new, richer scheme of fellowships.

Full Story


FierceBiotech Names Achaogen as One of the "Fierce 15" Biotech Companies of 2009

Published June 30, 2009, 4:30 am, Business Wire via Yahoo! Finance

SAN FRANCISCO----Achaogen, a clinical stage biopharmaceutical company addressing the issue of multi-drug resistant bacterial infections through the discovery and development of innovative broad-spectrum antibiotics, announced today that it has been selected as one of the annual FierceBiotech "Fierce 15" list, designating it as one of the top biotech companies of 2009.

Full Story


Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with ...

Published June 30, 2009, 4:00 am, PR Newswire via Yahoo! Finance

Calixa Therapeutics Inc. today announced the initiation of a Phase 2 clinical trial of CXA-101 in patients with complicated urinary tract infections.

Full Story


Funds for chlamydia drug to treat cystic fibrosis

Published June 29, 2009, 10:34 pm, NZPA via Yahoo!Xtra News

An antibiotic used to treat chlamydia will be funded for cystic fibrosis treatment from tomorrow, Government drug buying agency Pharmac announced today.

Full Story


Treatment funded to save patients and money

Published June 29, 2009, 7:58 pm, Scoop.co.nz

Funding azithromycin for cystic fibrosis is great news for patients and will save the health sector money, says Government drug-funder PHARMAC.

Full Story


Navigation: [ 1 2 Next ]

Are you looking for additional Drug Research > Antibiotic Resistance news? Try our new "Antibiotic Resistance News Focus" area.

Off-site Antibiotic Resistance Links, User Submitted

The following links have been collected through user bookmark submission in the Antibiotic Resistance category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Mon Jun 29

Sun Jun 28

Tue Jun 23

Fri May 15

Fri May 8

Tue May 5

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Antibiotic Resistance. If you would like to find related tags we recommend Tag Patterns > Antibiotic Resistance

Off-site Antibiotic Resistance Research Links

If you still need additional information on Antibiotic Resistance then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Drug Research

If you know the Drug Research Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Drug-Research.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

License

Creative Commons License This work is licensed under Creative Commons.


Your Ad Here
Your Ad Here

Powered by Odin Assemble 2.5a